Internal Medicine 2013-12-15 - Internal Medicine Alert - Dec 15, 2013

Target Audience:

This CME activity is intended for the internist/family physician.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Internal Medicine Alert has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/15/13. Term of approval is for one year from this date with the option of yearly renewal.

Faculty Listing:

Editor
Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Executive Editor
Leslie Coplin

Managing Editor
Neill Kimball

Associate Editors
Allan J. Wilke, MD
Professor and Chair
Program Director
Department of Family Medicine
Western Michigan University School of Medicine
Kalamazoo

William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Louis Kuritzky, MD

Clinical Assistant Professor
University of Florida
Gainesville

Authors
Rahul Gupta, MD, MPH, FACP
Clinical Assistant Professor,
West Virginia University School of Medicine,
Charleston, WV

Harold L. Karpman, MD, FACC, FACP
Clinical Professor of Medicine,
UCLA School of Medicine
Samir Kanani, MD
Associate Clinical Professor of Neurosurgery and Radiation Oncology,
George Washington University,
Radiation Oncology,
Inova Fairfax Hospital,
Falls Church, VA

Peer reviewer
Gerald Roberts, MD
Senior Attending Physician
Long Island Jewish Medical Center
NS/LIJ Health Care System
New Hyde Park, NY

Subjects:

  • Safety of Testosterone Replacement Questioned
  • Is Dabigatran Better Than Warfarin in Patients with Mechanical Heart Valves?
  • Modern Radiation Therapy and ADT for High-risk Prostate Cancer Result in Improved Survival

Objectives:

  • Describe new findings in differential diagnosis and treatment of various diseases
  • Describe the advantages, disadvantages and controversies surrounding the latest advances in the diagnosis and treatment of disease
  • Identify cost-effective treatment regimens
  • Explain the advantages and disadvantages of new disease screening procedures.

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton, MD, serves on the advisory board for Abbott, Amarin, Boehringer Ingelheim, Duchesnay, Janssen, Lilly, Novo Nordisk, Sunovion, and Teva; he serves on the speakers bureau of Boehringer Ingelheim, Janssen, Lilly, Novo Nordisk, and Teva. Peer reviewer Gerald Roberts, MD; executive editor Leslie Coplin; and managing editor Neill Kimball report no financial relationships relevant to this field of study.

Author Rahul Gupta, MD, MPH, FACP reports no financial relationships relevant to this field of study.

Author Harold L. Karpman, MD, FACC, FACP reports no financial relationships relevant to this field of study.

Author Samir Kanani, MD reports no financial relationships relevant to this field of study.

Authors Dr. Elliott and Dr. Chan report no financial relationships relevant to this field of study.